References
- Gale RP, Horowitz MM, Ash RC, et al. Identical-twin bone marrow transplants for leukemia. Ann Inter Med 1994;120:646–52.
- van Loghem JJ, Dorfmeier H, van der Hart M. Two A antigens with abnormal serological properties. Vox Sang 1957;2:16–24.
- Kolins J, Holland PV, McGinniss MH. Multiple red cell antigen loss in acute granulocytic leukemia. Cancer 1978;42:2248–53.
- Satheesh P, Thomas M, Rajan GB. Change in the ABO blood group phenotype. J Assoc Physicians India 1994;42:830.
- Chiewsilp P, Atichartakarn V. Change of red cell B antigen in a leukemic patient. J Med Assoc Thailand 1981;64:413–7.
- Yamada K, Yoshizaki Y, Fujii Y, et al. Concurrent ABO blood type change and erythrophagocytosis by leukemic cells in a case of acute myeloblastic leukemia. Acta Haematol Jpn 1985;48:1409–13.
- van der Hart M, van der Veer M, van Loghem JJ. Change of blood group B in a case of leukemia. Vox Sang 1962;7:449–53.
- Hoogstraten B, Rosenfield RE, Wasserman LR. Change of ABO blood type in a patient with leukemia.Transfusion 1961;1:32–5.
- Crookston MC. Anomalous ABO, H, Ii phenotypes in disease. In: Garratty G, ed. Blood group antigens and disease.Arlington,VA:American Association of Blood Banks, 1983:67–84.
- Yoshida A, Kumazaki T, Dave V, Blank J, Dzik WH. Suppressed expression of blood group B antigen and blood group galactosyltransferase in a preleukemic subject. Blood 1985;66:990–2.
- Reid ME, Bird GW. Associations between human red cell blood group antigens and disease. Transfus Med Rev 1990;4:47–55.
- Dobrovic A, O’Keefe D, Sage RE, Batchelder E. Imprinting and loss of ABO antigens in leukemia. Blood 1993;82:1684–5.
- Kuhns WJ, Oliver RT, Watkins WM, Greenwell P. Leukemia-induced alterations of serum glycosyltransferase enzymes. Cancer Res 1980;40:268–75.
- Salmon C. Blood group changes in preleukemic states. Blood Cells 1976;2:211–20.
- Lopez M, Bonnet-Gajdos M, Reviron M, Janvier D, Huet M, Salmon C. An acute leukaemia augured before clinical signs by blood group antigen abnormalities and low levels of A and H blood group transferase activities in erythrocytes. Br J Haematol 1986;63:535–9.
- Gold ER, Tovey GH, Benny WE, Lewis FJW. Changes in group A antigen in a case of leukaemia. Nature 1959;183:892–3.
- Treacy M, Geiger J, Goss MF. Substances in serum causing interference with blood group determination.Transfusion 1967;7:443–6.
- Levan A, Nichols WW, Hall B, Low B, Nilsson SB, Norden A. Mixture of Rh positive and Rh negative erythrocytes and chromosomal abnormalities in a case of polycythemia. Hereditas 1964;52:89–105.
- Majsky A. Some cases of leukaemia with modifications of the D(Rho)-receptor. Neoplasma 1967;14:335–44.
- Cooper B, Tishler PV, Atkins L, Breg WR. Loss of Rh antigen associated with acquired Rh antibodies and a chromosome translocation in a patient with myeloid metaplasia. Blood 1979;54:642–7.
- Bracey AW, McGinniss MH, Levine RM, Whang-Peng J. Rh mosaicism and aberrant MNSs antigen expression in a patient with chronic myelogenous leukemia. Am J Clin Pathol 1983;79:397–401.
- van Bockstaele DR, Berneman ZN, Muylle L, Cole-Dergent J, Peetermans ME. Flow cytometric analysis of erythrocytic D antigen density profile. Vox Sang 1986;51:40–6.
- Mohandas V, Najfeld H, Gilbert P, Azar D, Tabrizi D. Loss and reappearance of Rho antigen in an individual with acute myelogenous leukemia (abstract).Transfusion 1993;33:24s.
- Cherif-Zahar B, Bony V, Steffensen R, et al. Shift from Rh-positive to Rh-negative phenotype caused by a somatic mutation within the RHD gene in a patient with chronic myelocytic leukaemia. Br J Haematol 1998;102:1263–70.
- Tovey GH, Lockyer JW, Tierney RB. Changes in Rh grouping reactions in a case of leukaemia. Vox Sang 1961;6:628–31.
- Callender ST, Kay HE, Lawler SD, Millard RE, Sanger R, Tippett PA. Two populations of Rh groups together with chromosomally abnormal cell lines in the bone marrow. Br Med J 1971;1:131–3.
- Habibi B, Lopez M, Salmon C. Two new cases of Rh mosaicism. Selective study of red cell populations. Vox Sang 1974;27:232–42.
- Mertens G, Gielis M, Muylle L, de Raedt S. Loss of D and C expression in chronic myelomonocytic leukemia.Transfusion 1997;37:880–1.
- Kolins J, Allgood JW, Burghardt DC, Klein HG, McGinniss MH. Modifications of B, I, i, and Lewisb antigens in a patient with DiGuglielmo’s erythroleukemia.Transfusion 1980;20:574–7.
- Csato E, Vass E. Frequency of Lewis group substances in patients with cancer of stomach. Haematologia (Budap) 1989;22:55–9.
- Schmidt PJ, Yokoyama M, McGinniss MH, Carbone PP. Effect of disease on an expression of blood group I. Bibl Haematol 1965;23:343–5.
- Jenkins WJ, Marsh WL, Gold ER. Reciprocal relationship of antigens I and i in health and disease. Nature 1965;205:813.
- Giblett ER, Crookston MC. Agglutinability of red cells by anti-i in patients with thalassemia major and other haematological disorders. Nature 1964;201:1138–9.
- Perkins HA, McIlroy M, Swanson J, Kadin M. Transient LW-negative red blood cells and anti-LW in a patient with Hodgkin’s disease. Vox Sang 1977;33:299–303.
- Komatsu F, Kajiwara M. Transient depression of LWa antigen with coincident production of anti-LWa repeated in relapses of malignant lymphoma. Transfus Med 1996;6:139–43.
- Chown B, Kaita H, Lowen B, Lewis M. Transient production of anti-LW by LW-positive people. Transfusion 1971;11:220–2.
- 37.Poole J, Williamson LM, Clark N, Black A. Loss of Lutheran and LW antigen expression in a patient with autoimmune thrombocytopenic purpura (ITP) (abstract).Transfusion 1991;31:38s. 38.de la Chapelle A, Vuopio P, Sanger R, Teesdale P. Monosomy-7 and the Colton blood-groups. Lancet 1975;2:817.
- Boetius G, Hustinx TW, Smits AP, Scheres JM, Rutten FJ, Haanen C. Monosomy 7 in two patients with a myeloproliferative disorder. Br J Haematol 1977;37:101–9.
- Pasquali F, Bernasconi P, Casalone R, et al. Pathogenetic significance of “pure” monosomy 7 in myeloproliferative disorders. Analysis of 14 cases. Hum Genet 1982;62:40–51.
- Telen MJ, Rao N, Udani M, Liao H-X, Haynes BF. The AnWj blood group antigen/Hemophilus influenzae receptor resides on a high-molecular weight protein expressed by CD44 transfectants. Clin Res 1993;41:161A.
- Mannessier L, Rouger P, Johnson CL, Mueller KA, Marsh WL. Acquired loss of red-cell Wj antigen in a patient with Hodgkin’s disease. Vox Sang 1986;50:240–4.
- Yomtovian R, Prince GM, Medof ME. The molecular basis for paroxysmal nocturnal hemoglobinuria. Transfusion 1993;33:852–73.
- Dunn DE, Tanawattanacharoen P, Boccuni P, et al. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med 1999;131:401–8.
- Cartron JP, Andreu G, Cartron J, Bird GW, Salmon C, Gerbal A. Demonstration of T-transferase deficiency in Tn-polyagglutinable blood samples. Eur J Biochem 1978;92:111–9.
- Vengelen-Tyler V, ed. Technical manual. 13th ed. Bethesda, MD: American Association of Blood Banks, 1999.
- Bird GW, Wingham J, Pippard MJ, Hoult JG, Melikian V. Erythrocyte membrane modification in malignant diseases of myeloid and lymphoreticular tissues. I. Tn-polyagglutination in acute myelocytic leukaemia. Br J Haematol 1976;33:289–94.
- Roxby DJ, Morley AA, Burpee M. Detection of the Tn antigen in leukaemia using monoclonal anti-Tn antibody and immunohistochemistry. Br J Haematol 1987;67:153–6.
- Roxby DJ, Pfeiffer MB, Morley AA, Kirkland MA. Expression of the Tn antigen in myelodysplasia, lymphoma, and leukemia. Transfusion 1992;32: 834–8.
- Ness PM, Garratty G, Morel PA, Perkins HA. Tn polyagglutination preceding acute leukemia. Blood 1979;54:30–4.
- Bird GW, Wingham J, Richardson SG. Myelofibrosis, autoimmune haemolytic anaemia and Tn polyagglutinability. Haematologia (Budap) 1985; 18:99–103.